Hi,
My name is Isabel.
I am Portuguese and I live in Portugal.
My message is related to a diagnosis of prostate adenocarcinoma, Gleason (3 + 4), initially staged with a T2b N0 M0, to my father, last year, at the age of 60.
On May 1, 2019 he underwent radical radiotherapy without hormone therapy. Completed treatment on May 22, 2019. 5 intense sessions. PSA after treatment dropped from 9.3 to 7.6.
However, starting in March, he had biochemical recurrence criteria, underwent examinations and presented bone and ganglionic metastasis with a PSA of 47.5.
It was suggested by his doctor to do hormone therapy with an LHRH analogue and evaluation in Medical Oncology to perform concomitant chemotherapy (docetaxel).
He also started with the treatment (just one session), but had mucositis. The treatment will continue in the next week.
I know what I ask of you is ungrateful, but do you have any guidance you can give us?
Any recommendations from an expert in Europe/Portugal? Any clinical trial?
Is there a very bad prognosis?
Best,